ARRHYTHMIA PROPHYLAXIS WITH PROCAINE AMIDE: PLASMA CONCENTRATIONS IN RELATION TO DOSE
Authors:
- 12 January 1973
- journal article
- clinical trial
- Published by Wiley in Acta Medica Scandinavica
- Vol. 194 (1-6) , 405-411
Abstract
Forty patients with suspected or confirmed acute myocardial infarction have been treated with procaine amide orally because of ventricular arrhythmia. The patients were divided into three groups with respect to doses and dosage intervals. Frequent determinations of the concentration of procaine amide in plasma were performed by a fluorometric method. Plasma concentrations between 4 and 6 μg/ml, which have been reported to be the therapeutic range, were achieved only with one of the dose schedules employed, i.e. a total daily dose of 50 mg/kg b.wt., administered in divided doses every 3 hours. However, even a 4‐hour administration interval may give rather acceptable plasma concentrations. In patients with cardiac and renal insufficiency the dose must be individually reduced.Keywords
This publication has 7 references indexed in Scilit:
- Metabolism of procainamide in rhesus monkey and manClinical Pharmacology & Therapeutics, 1972
- Procainamide Dosage Schedules, Plasma Concentrations, and Clinical EffectsJAMA, 1971
- Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial InfarctionNew England Journal of Medicine, 1969
- The Use of procaine amide and lidocaine in the treatment of cardiac arrhythmiasProgress in Cardiovascular Diseases, 1969
- Procaine AmideCirculation, 1957
- The Use of Procaine Amide in Cardiac ArrhythmiasCirculation, 1951
- THE PHYSIOLOGICAL DISPOSITION AND CARDIAC EFFECTS OF PROCAINE AMIDEThe Journal of Pharmacology and Experimental Therapeutics, 1951